youtube_live
Q3 2026 earnings • 11:30 PM today
See detailschevron_right
GH:NASDAQ
Guardant Health Inc
158,62 USD
arrow_downward
-5,91%(-9,96) 1D
5-ноя., 11:22:43 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
165,00 USD
High
165,10 USD
Low
151,92 USD
Mkt. cap
21,16 млд
Avg. vol.
1,81 млн
Volume
1,17 млн
52-wk high
191,05 USD
52-wk low
74,55 USD
EPS
-3,50 USD
Beta
1,67
Shares outstanding
134,20 млн
No. of employees
2 миң
Open
165,00 USD
High
165,10 USD
Low
151,92 USD
Mkt. cap
21,16 млд
Avg. vol.
1,81 млн
Volume
1,17 млн
52-wk high
191,05 USD
52-wk low
74,55 USD
EPS
-3,50 USD
Beta
1,67
Shares outstanding
134,20 млн
No. of employees
2 миң
News stories
From web sources and news partners
Yahoo! Finance Canada
·
11 саат мурун
Will Shield Award Recognition Change Guardant Health Stock Narrative
Zacks
·
18 саат мурун
Cytokinetics (CYTK) Reports Q3 Loss, Beats Revenue Estimates
Zacks
·
1 күн мурун
Countdown to Guardant Health (GH) Q3 Earnings: Wall Street Forecasts for Key Metrics
Investing.com India
·
2 күн мурун
Form 8K Guardant Health Inc For: 3 November By Investing.com
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 миң
Founded2012
HeadquartersПало Альто, Калифорния, Америка Кошмо Штаттары
SectorHealth care provider
Industry-
Websiteguardanthealth.com